www.mdanderson.org/newsroom/res...
www.mdanderson.org/newsroom/res...
with @LuisRaezMD @mhshospital @MikeCusnir @MountSinaiMiami @BrunaPellini @MoffitNews
🗓️ Thu, March 13thm 5:0PM-8:00PM
📍 Trump International Resort, Sunny Isles FL
@sylvestercancer #lcsm
with @LuisRaezMD @mhshospital @MikeCusnir @MountSinaiMiami @BrunaPellini @MoffitNews
🗓️ Thu, March 13thm 5:0PM-8:00PM
📍 Trump International Resort, Sunny Isles FL
@sylvestercancer #lcsm
apnews.com/article/brea...
apnews.com/article/brea...
#ONCOnews #OncoAlert #OncEd #OncologyNews #CancerUpdates #CancerResearch #BreastCancer
#ONCOnews #OncoAlert #OncEd #OncologyNews #CancerUpdates #CancerResearch #BreastCancer
#ONCOnews #OncoAlert #OncEd #OncologyNews #CancerUpdates #CancerResearch #BreastCancer
#ONCOnews #OncoAlert #OncEd #OncologyNews #CancerUpdates #CancerResearch #BreastCancer
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates #FDAApproval #NSCLC
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates #FDAApproval #Hematology #DrugApproval
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates #FDAApproval #NeuroOncology
✅ FDA grants full approval to Amgen's IMDELLTRA® (tarlatamab-dlle) in extensive stage small cell lung cancer (ES-SCLC).
🎯 Phase 3 DeLLphi-304 shows 40% reduction in risk of death vs chemo.
🔗 Read more: bit.ly/ONCOnews20N3
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates
✅ FDA grants full approval to Amgen's IMDELLTRA® (tarlatamab-dlle) in extensive stage small cell lung cancer (ES-SCLC).
🎯 Phase 3 DeLLphi-304 shows 40% reduction in risk of death vs chemo.
🔗 Read more: bit.ly/ONCOnews20N3
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates
#ONCOnews #OncoAlert #OncEd #Oncology #CancerUpdates #LymphomaTreatment